<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200203046360N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-30</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>effect of whole body vibration on muscle inhibition</public_title>
      <acronym></acronym>
      <scientific_title>study effect of whole body vibration on arthrogenic muscle inhibition of quadriceps muscle in knee osteoarthritis patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45549</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Factorial, Purpose: Treatment, Randomization description: First, when the sampling is done in a simple and accessible way, each sample is given a specific code, then each code is written on a piece of paper and the papers are poured into a container, the number of samples of each group is drawn and The number of papers randomly leaves the container, Blinding description: Keeping participants blind so that patients in the intervention group are visited on even days and the control group is visited on individual days, and each group is unaware of the existence of the other group.
Keeping blind variables assessor in such a way that at the time of testing the variables, the assessor is unaware of the type of group therapy and only measured the variables in all participants.
Keeping the data analyst blind so that he is unaware of each patient's treatment group at the time of reviewing and analyzing the data, and each patient is introduced to the analyzer with only one identifier code.</study_design>
      <phase>N/A</phase>
      <hc_freetext>knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: whole-body vibration group                                 Vibration frequency: Hz 30/ Vibration amplitude: mm 4 (peak to peak)/ Vibration type: Vertical vibration/ Vibration acceleration: g8.24/ Exercise position: standing, with 30 degrees of flexion, without socks and shoes/ exercise duration: 30 seconds/ Rest duration Between Each Exercise: 60 Seconds/ Number of repetitions in each set: 4 times/ Number of sets: 2 to 4 sets (first, second and third sessions 2 sets / fourth, fifth and sixth sessions 3 sets / seventh, eighth, ninth and tenth sessions 4 sets)/ Rest duration between each set: 5 minutes                                                                Routine physiotherapy treatment includes: 20-minute electrical stimulation / 5-minute ultrasound therapy and quadriceps muscle strengthening exercises. Intervention 2: Intervention group: placebo                                                                          Use the whole body vibration device for 4 sets of 30 seconds per set and rest for 60 seconds between each set while the device is off and has no vibration.                                                                                                  Routine physiotherapy treatment includes: 20-minute electrical stimulation / 5-minute ultrasound therapy and quadriceps muscle strengthening exercises. Intervention 3: Control group: control                                                                                 Routine physiotherapy treatment includes: 20-minute electrical stimulation / 5-minute ultrasound therapy and quadriceps muscle strengthening exercises.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
may share the main results of the study

When:
after the end of the study in1399

To whom:
for the academic researchers

Conditions:
analysis results in each group are able to represent as tables and graphs

Where to obtain:
The main presenter, Dr. Khosrow Khademi Kalantari, Professor, Department of Physiotherapy, Faculty of Rehabilitation, Shahid Beheshti University of Medical Sciences

How to obtain:
After submitting a written request to the main executor and stating the reason for the data request, if the main executor is approved, the data file will be provided as needed.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Khosro Khademi-Kalantari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dep of Physiotherapy, School of Rehabilitation Sciences, Shahid Beheshti UN of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7756 1721</telephone>
        <email>khosro_khademi@yahoo.co.uk</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Khosro Khademi-Kalantari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dep of Physiotherapy, School of Rehabilitation Sciences, Shahid Beheshti UN of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7756 1721</telephone>
        <email>khosro_khademi@yahoo.co.uk</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>patients with primary knee osteoarthritis in grade2 or 3 based on kellgren and lawrence criteria
patients with chronic knee pain (feeling pain in knee or around of it in most of the time, feeling pain in knee for recent year)
age range between 30 and 60
no participant in strengthening program from 6 month ago
BMI between 22 and 30
having at least 10% arthrogenic muscle inhibition in quadriceps muscle of affected knee</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>severe cardiovascular disease which prevents exercising
drug addiction
total knee arthroplasty or any other surgery on lower limb
pain score more than 5 based on VAS during study
knee surgery history , rheumatoid disease or septic knee , cancer
secondary osteoarthritis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M15.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Primary generalized (osteo)arthritis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: whole-body vibration group                                 Vibration frequency: Hz 30/ Vibration amplitude: mm 4 (peak to peak)/ Vibration type: Vertical vibration/ Vibration acceleration: g8.24/ Exercise position: standing, with 30 degrees of flexion, without socks and shoes/ exercise duration: 30 seconds/ Rest duration Between Each Exercise: 60 Seconds/ Number of repetitions in each set: 4 times/ Number of sets: 2 to 4 sets (first, second and third sessions 2 sets / fourth, fifth and sixth sessions 3 sets / seventh, eighth, ninth and tenth sessions 4 sets)/ Rest duration between each set: 5 minutes                                                                Routine physiotherapy treatment includes: 20-minute electrical stimulation / 5-minute ultrasound therapy and quadriceps muscle strengthening exercises</i_keyword>
      <i_keyword>Intervention group: placebo                                                                          Use the whole body vibration device for 4 sets of 30 seconds per set and rest for 60 seconds between each set while the device is off and has no vibration.                                                                                                  Routine physiotherapy treatment includes: 20-minute electrical stimulation / 5-minute ultrasound therapy and quadriceps muscle strengthening exercises</i_keyword>
      <i_keyword>Control group: control                                                                                 Routine physiotherapy treatment includes: 20-minute electrical stimulation / 5-minute ultrasound therapy and quadriceps muscle strengthening exercises</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Arthrogenic muscle inhibition of quadriceps. Timepoint: before any intervention, after first session, end of ten session , one month follow up. Method of measurement: quantitative measurement using digital dianamometer.</prim_outcome>
      <prim_outcome>Maximal voluntary isometric contraction. Timepoint: before any intervention, after the first session, end of ten-session, one month follow up. Method of measurement: quantitative measurement of muscle strength using digital dinamometer.</prim_outcome>
      <prim_outcome>Pain. Timepoint: before any intervention, after the first session, end of ten-session, one month follow up. Method of measurement: using VAS.</prim_outcome>
      <prim_outcome>Function. Timepoint: before any intervention, after the first session, end of ten-session, one month follow up. Method of measurement: using 6 minute waking test.</prim_outcome>
      <prim_outcome>Balance. Timepoint: before any intervention, after the first session, end of ten-session, one month follow up. Method of measurement: using berg balance scale.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: before any intervention, after the first session, end of ten-session, one month follow up. Method of measurement: using WHO-QOL brief questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-26</approval_date>
        <contact_name>Ethics committee of shahid behshti medical university</contact_name>
        <contact_address>next to Ayatollah Taleghani Hospital, Shahid Arabi St., Yemen St., Shahid Chamran Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
